We are monitoring the impact of COVID-19 on Asia Pacific Psychiatry Therapies Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4356
Share on
Share on

Asia Pacific Psychiatry Therapies Market Size, Share, Trends and Growth Analysis Report – Segmented By Type, Type Of Medication, Type Of Therapy and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Growth, Trends and Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4356
Pages: 141

APAC Psychiatry Therapies Market Size (2020 to 2025)

The size of the Psychiatry Therapies Market in Asia Pacific is estimated to expand at a high rate from 2020 to 2025.

Psychiatry Therapies cam be defined as therapeutic interaction processes between patients and trained psychiatric professionals in order to treat psychological problems of patients. Psychiatric therapies involve the treatment of mental and emotional disorders and behaviour disturbance by using psychological therapies and techniques. These psychiatry therapies are planned to modify the behaviour of a patient and provide relief from disorders.

Psychiatry therapies fundamentally rely on establishing relationship between psychiatry therapist and patients for developing a patient’s behavioural insights. Psychiatry therapist use electrical shocks or psychological drugs to change the emotions of their patients. Verbal and Non-verbal communication with the patient and other physical intervention is also beneficial in the treatment of psychiatry patients. In addition, adjuvant therapies like occupational therapies and music therapies are also helpful during the treatment. All of these therapies aim to improve the well-being of patients by employing range of relationships and psychological techniques.

The key driving factor of Asia Pacific psychiatry therapies market is the rising prevalence of mental and emotional health issues. This rising incidence of psychological ailments is going to rise the demand for treatment, resulting in the growth of this market. Rising stress condition, emotional, physical and mental pressure among population is also increasing the demand of psychiatry therapies and resulting in the growth of psychiatry therapies market. In addition, rising chronic diseases and anxiety disorders will further drive the market of psychiatry therapies. However, the market is constrained by factors like strict regulations for practising psychotherapy by various governments.

This research report on the Asia Pacific Psychiatry Therapies Market has been segmented and sub-segmented into the following categories:

  • By Psychology Type: Social Psychology, Abnormal Psychology, Biological Psychology and Others
  • By Type of Medication: Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers, Stimulants and Others
  • By Type of Therapy: Counselling, Cognitive Behavioural Therapy, Family Therapy, Psychotherapy, Group Therapy, Relationship Counselling, Interpersonal Therapy, Behavioural Activation and Others
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, Asia Pacific has the third largest market for psychiatry therapy in the world by share. It is also the fastest growing region in the world, owing to factors such as rising awareness about mental health and changing lifestyles. Factors such as growing prevalence of psychological ailments and stress levels is expected to result in the growth of this market.

Key market players in the Asia Pacific Psychiatry Therapies market are Astrazeneca, Universal Health Services Inc., Johnson & Johnson, Pfizer, GlaxoSmithKline, Eli Lilly, Bristol-Meyer Squibb, Wyeth, Astellas Pharma Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Social Psychology 

                                5.1.2 Abnormal Psychology         

                                5.1.3 Biological Psychology          

                                5.1.4 Other Types           

                                5.1.5  Y-o-Y Growth Analysis, By Type    

                                5.1.6  Market Attractiveness Analysis, By Type  

                                5.1.7  Market Share Analysis, By Type    

                5.2 Type of Medication                 

                                5.2.1 Antidepressants   

                                5.2.2 Antipsychotics       

                                5.2.3 Depressants           

                                5.2.4 Anxiolytics               

                                5.2.5 Mood Stabilisers   

                                5.2.6 Stimulants               

                                5.2.7 Other Types of Medication              

                                5.2.8 Y-o-Y Growth Analysis, By Type of Medication        

                                5.2.9 Market Attractiveness Analysis, By Type of Medication      

                                5.2.10 Market Share Analysis, By Type of Medication     

                5.3 Type of Therapy                       

                                5.3.1 Counselling             

                                5.3.2 Cognitive Behavioural Therapy       

                                5.3.3 Family Therapy      

                                5.3.4 Psychotherapy      

                                5.3.5 Group Therapy      

                                5.3.6 Relationship Counselling   

                                5.3.7 Interpersonal Therapy       

                                5.3.8 Behavioural Activation       

                                5.3.9 Other Types of Therapy    

                                5.3.10 Y-o-Y Growth Analysis, By Type of Therapy            

                                5.3.11  Market Attractiveness Analysis, By Type of Therapy         

                                5.3.12  Market Share Analysis, By Type of Therapy           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Type

                                                6.1.3.2 By Type of Medication

                                                6.1.3.3 By Type of Therapy

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Type

                                                6.1.4.2 By Type of Medication

                                                6.1.4.3 By Type of Therapy

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Type

                                                6.1.5.2 By Type of Medication

                                                6.1.5.3 By Type of Therapy

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Astrazeneca                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Universal Health Services Inc.                             

                8.3 Johnson & Johnson                 

                8.4 Pfizer                            

                8.5 GlaxoSmithKline                       

                8.6 Eli Lilly                           

                8.7 Bristol-Meyer Squibb                             

                8.8 Wyeth                          

                8.9 Astellas Pharma Inc.                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  2. Asia Pacific Social Psychology Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia Pacific Abnormal Psychology Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia Pacific Biological Psychology Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia Pacific Other Types Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia Pacific Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  7. Asia Pacific Antidepressants Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia Pacific Antipsychotics Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia Pacific Depressants Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia Pacific Anxiolytics Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia Pacific Mood Stabilisers Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia Pacific Stimulants  Market, By Region, From 2020 to 2025 (USD Million)
  13. Asia Pacific Other Types of Medication Market, By Region, From 2020 to 2025 (USD Million)
  14. Asia Pacific Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)
  15. Asia Pacific Counselling Market, By Region, From 2020 to 2025 (USD Million)
  16. Asia Pacific Cognitive Behavioural Therapy Market, By Region, From 2020 to 2025 (USD Million)
  17. Asia Pacific Family Therapy Market, By Region, From 2020 to 2025 (USD Million)
  18. Asia Pacific Psychotherapy Market, By Region, From 2020 to 2025 (USD Million)
  19. Asia Pacific Group Therapy Market, By Region, From 2020 to 2025 (USD Million)
  20. Asia Pacific Relationship Counselling Market, By Region, From 2020 to 2025 (USD Million)
  21. Asia Pacific Interpersonal Therapy Market, By Region, From 2020 to 2025 (USD Million)
  22. Asia Pacific Behavioural Activation  Market, By Region, From 2020 to 2025 (USD Million)
  23. Asia Pacific Other Types of Therapy Market, By Region, From 2020 to 2025 (USD Million)
  24. Japan Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  25. Japan Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  26. Japan Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)
  27. China Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  28. China Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  29. China Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)
  30. India Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  31. India Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  32. India Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)
  33. Australia Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  34. Australia Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  35. Australia Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)
  36. South Korea Psychiatry Therapies Market, By Type , From 2020 to 2025 (USD Million)
  37. South Korea Psychiatry Therapies Market, By Type of Medication , From 2020 to 2025 (USD Million)
  38. South Korea Psychiatry Therapies Market, By Type of Therapy , From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample